Wednesday, 12 December 2018

13th December, 2018 Morning Brief

Another gap up opening expected supported by lower inflation figures and Asian markets which ticked higher alongside U.S. equity futures on Thursday after a series of positive developments in U.S.-China trade talks buoyed global stocks.

Nifty50 formed robust bullish candle on the daily chart for the second consecutive session. Nifty has resistance at 10740 & 10850 and we may witness a profit booking around these levels. 10600 is the immediate support level for Nifty50.

🎯 News & Impact 🎯

October IIP at 8.1% Vs 4.5% (MoM)

November CPI at 2.33% Vs 3.38% (MoM)

🎯 Sun Pharma :
Company’s Taro received tentative ANDA approval for Dapsone by the U.S. FDA.
Positive for the stock. 👍

🎯 Lupin :
Company announced that European Union’s General Court upheld European Commission’s decision in Perindopril litigation. The pharma company is liable to pay fine of 40 million euros.
Negative for the stock.

🎯 Strides Pharma Sciences :
Company's Singapore arm received U.S. FDA approval for Lidocaine Ointment.
Positive for the stock. 👍

🎯 Bandhan Bank :
RBI allowed the bank to open 40 new branches. 
Positive for the stock. 👍

🎯 Pricol :
Company signed a joint venture agreement with Israel-based mobile resource management company ‘Pointer Telocation’ to provide digital telematic solutions to both OEM and after-market segment players in India and other countries in South East Asia.

Edited by Sharp.

No comments:

Post a Comment